BBP:NYE-Virtus LifeSci Biotech Products ETF (USD)

ETF | Health |

Last Closing

USD 62.3351

Change

0.00 (0.00)%

Market Cap

USD 0.02B

Volume

1.35K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-02 )

ETFs Containing BBP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.86% 24% F 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.86% 24% F 69% C-
Trailing 12 Months  
Capital Gain 8.02% 67% D+ 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.02% 57% F 45% F
Trailing 5 Years  
Capital Gain 43.93% 95% A 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.93% 81% B- 62% D
Average Annual (5 Year Horizon)  
Capital Gain 7.94% 86% B+ 60% D-
Dividend Return 7.94% 86% B+ 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.37% 57% F 59% D-
Risk Adjusted Return 43.26% 76% C+ 57% F
Market Capitalization 0.02B 20% F 12% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.